Pharmacovigilance 101: What is it and why is it important?

February 23, 2012

Presented by Dr. Richard Dolinar, MD What is pharmacovigilance Track & Trace systems for biologic medicines Coding, Naming, Labeling Down the Road: Interchangeability and Drug Substitution

Read More


Biosimilars 101: What are biosimilars and why should you care?

December 1, 2011

Presented by Dr. Richard Dolinar, MD What are biosimilars Why are biosimilars not generics Manufacturing The FDA’s “biosimilar pathway” Policy Considerations

Read More


Biologics 101: What are biologics and why should you care?

November 17, 2011

Presented by Alliance Chairman, Dr. Richard Dolinar, MD Role of biotechnology in medical advancements What are biologics Examples of biologic medicines Manufacturing process Chemical drugs vs. biologic medicines Implications of size, variability, complexity What’s next for biotechnology

Read More